Triology Writing and Consultancy

Trilogy Writing & Consulting is a specialized medical writing consultancy serving pharmaceutical, biotechnology, clinical research, and medical device clients. The company focuses on clinical, regulatory, safety, and medical content, with particular strength in preparing regulatory documentation and submission dossiers across all phases of drug development. Its services include protocols, clinical study reports, investigator brochures, CTD modules, DSURs, risk management plans, briefing books, manuscripts, and other scientific communications. Trilogy has operated for more than two decades and works as an outsourced strategic writing partner embedded with client teams. In March 2024, Trilogy Writing & Consulting GmbH was acquired by Indegene, expanding Indegene's clinical and regulatory writing capabilities.